PerkinElmer inks $155M Immunodiagnostic buyout, continuing deal spree

PerkinElmer has struck a deal to buy Immunodiagnostic Systems Holdings (IDS) for $155 million to grow its diagnostics business, continuing the company's 2021 spending spree.